EPIDEMIOLOGICAL PROFILE OF MALIGNANT NEOPLASIA OF THE PANCREAS IN ADULTS IN BRAZIL BETWEEN 2017 TO 2022
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/1159 |
Resumo: | INTRODUCTION: Pancreatic cancer has a very unfavorable prognosis, with less than 10% survival rate within 5 years after diagnosis. Generally asymptomatic at first, it makes early detection difficult and spreads quickly. Risk factors include age, smoking and obesity, with the latter associated with a higher incidence. Surgical resection, a potentially curative method, is rare due to the location and late detection of tumors, which results in a fatal outcome. Primary health care is crucial in prevention, especially to minimize socioeconomic disparities that can affect incidence. OBJECTIVE: To describe the epidemiological profile of Malignant Neoplasia of the Pancreas in adults in Brazil between 2017 to 2022. METHODOLOGY: Cross-sectional descriptive study with a quantitative and qualitative approach, based on the collection of data present in the Hospital Information System, hosted at DATASUS on Malignant Neoplasia of the Pancreas reported in Brazil between the periods of 2017 and 2022. The data totaled 78,796 hospitalizations in this period. The indicators used were: federation units; gender; age group; education; evolution of the case to death, race/ethnicity and region of occurrence. For the literature review, the keywords and the main subject about Malignant Neoplasia of the Pancreas were relevant using the SciELO and PubMed database platforms. Articles published in the last 13 years that emphasized the description of the disease, its risk factors, the most prevalent histological types, as well as symptoms and prognosis were selected. RESULTS: Between 2017 and 2022, Brazil recorded 78,796 hospitalizations for Malignant Neoplasia of the Pancreas. The Southeast region had the highest occurrence, with 47.5% of cases, with SP being the most affected state, followed by MG, RS and PR. CONCLUSION: From 2017 to 2022, pancreatic cancer was more prevalent in Southeast Brazil, mainly in São Paulo, totaling 78,796 cases. Population density, socioeconomic conditions and access to advanced medical centers influenced this distribution. Adenocarcinoma represented 90% of cases. Remarkable advances have been made, including the identification of risk factors such as smoking and obesity, and the association with glucose problems and diabetes as early indicators. CT scanning is vital for diagnosis, but understanding genetic mutations remains a necessary area of investigation. |
id |
GOE-1_e0ac003438cd36c13fede69bb1b2d7be |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/1159 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
repository_id_str |
|
spelling |
EPIDEMIOLOGICAL PROFILE OF MALIGNANT NEOPLASIA OF THE PANCREAS IN ADULTS IN BRAZIL BETWEEN 2017 TO 2022PERFIL EPIDEMIOLÓGICO DA NEOPLASIA MALÍGNA DE PÂNCREAS EM ADULTOS NO BRASIL ENTRE 2017 A 2022Saúde masculina, Neoplasia, Pâncreas, tumores.Men's health, Neoplasia, Pancreas, tumors.INTRODUCTION: Pancreatic cancer has a very unfavorable prognosis, with less than 10% survival rate within 5 years after diagnosis. Generally asymptomatic at first, it makes early detection difficult and spreads quickly. Risk factors include age, smoking and obesity, with the latter associated with a higher incidence. Surgical resection, a potentially curative method, is rare due to the location and late detection of tumors, which results in a fatal outcome. Primary health care is crucial in prevention, especially to minimize socioeconomic disparities that can affect incidence. OBJECTIVE: To describe the epidemiological profile of Malignant Neoplasia of the Pancreas in adults in Brazil between 2017 to 2022. METHODOLOGY: Cross-sectional descriptive study with a quantitative and qualitative approach, based on the collection of data present in the Hospital Information System, hosted at DATASUS on Malignant Neoplasia of the Pancreas reported in Brazil between the periods of 2017 and 2022. The data totaled 78,796 hospitalizations in this period. The indicators used were: federation units; gender; age group; education; evolution of the case to death, race/ethnicity and region of occurrence. For the literature review, the keywords and the main subject about Malignant Neoplasia of the Pancreas were relevant using the SciELO and PubMed database platforms. Articles published in the last 13 years that emphasized the description of the disease, its risk factors, the most prevalent histological types, as well as symptoms and prognosis were selected. RESULTS: Between 2017 and 2022, Brazil recorded 78,796 hospitalizations for Malignant Neoplasia of the Pancreas. The Southeast region had the highest occurrence, with 47.5% of cases, with SP being the most affected state, followed by MG, RS and PR. CONCLUSION: From 2017 to 2022, pancreatic cancer was more prevalent in Southeast Brazil, mainly in São Paulo, totaling 78,796 cases. Population density, socioeconomic conditions and access to advanced medical centers influenced this distribution. Adenocarcinoma represented 90% of cases. Remarkable advances have been made, including the identification of risk factors such as smoking and obesity, and the association with glucose problems and diabetes as early indicators. CT scanning is vital for diagnosis, but understanding genetic mutations remains a necessary area of investigation.INTRODUÇÃO: O câncer de pâncreas tem um prognóstico muito desfavorável, com menos de 10% de sobrevida em 5 anos após o diagnóstico. Geralmente assintomático no início, dificulta a detecção precoce e propaga-se rapidamente. Fatores de risco incluem idade, tabagismo e obesidade, com esta última associada a uma maior incidência. A ressecção cirúrgica, método potencialmente curativo, é rara devido à localização e detecção tardia dos tumores, o que resulta em um desfecho fatal. A atenção primária à saúde é crucial na prevenção, especialmente para minimizar disparidades socioeconômicas que podem afetar a incidência. OBJETIVO: Descrever o perfil epidemiológico da Neoplasia Malígna de Pâncreas em adultos no Brasil entre 2017 a 2022. METODOLOGIA: Estudo transversal descritivo com abordagem quantitativa e qualitativa, baseado na coleta dos dados presentes no Sistema de Informações Hospitalares, hospedado no DATASUS sobre a Neoplasia Maligna de Pâncreas notificadas no Brasil entre os períodos de 2017 a 2022. Os dados totalizaram 78.796 internações nesse período. Os indicadores utilizados foram: unidades da federação; gênero; faixa etária; escolaridade; evolução do caso para óbito, raça/etnia e região de ocorrência. Para a revisão de literatura foi pertinente às palavras-chave e o assunto principal sobre a Neoplasia Maligna de Pâncreas utilizando as bases de dados plataformas SciELO e PubMed. Foram selecionados artigos publicados nos últimos 13 anos e que apresentassem ênfase na descrição da doença, seus fatores de risco, os tipos histológicos mais prevalentes, bem como os sintomas e prognóstico. RESULTADOS: Entre 2017 e 2022, o Brasil registrou 78.796 internações por Neoplasia Maligna de Pâncreas. A região Sudeste teve a maior ocorrência, com 47,5% dos casos, sendo SP o estado mais afetado, seguido de MG, RS e PR. CONCLUSÃO: De 2017 a 2022, o câncer de pâncreas foi mais prevalente no Sudeste do Brasil principalmente em São Paulo, totalizando 78.796 casos. A densidade populacional, condições socioeconômicas e acesso a centros médicos avançados influenciaram essa distribuição. O adenocarcinoma representou 90% dos casos. Avanços notáveis foram feitos, incluindo a identificação de fatores de risco como tabagismo e obesidade, e a associação com problemas de glicose e diabetes como indicadores precoces. A tomografia computadorizada é vital para o diagnóstico, mas a compreensão das mutações genéticas continua sendo uma área de investigação necessária.Specialized Dentistry Group2023-12-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/115910.36557/2674-8169.2023v5n5p6444-6453Brazilian Journal of Implantology and Health Sciences ; Vol. 5 No. 5 (2023): BJIHS QUALIS B3; 6444-6453Brazilian Journal of Implantology and Health Sciences ; Vol. 5 Núm. 5 (2023): BJIHS QUALIS B3; 6444-6453Brazilian Journal of Implantology and Health Sciences ; v. 5 n. 5 (2023): BJIHS QUALIS B3; 6444-64532674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1159/1321Copyright (c) 2023 Maria Eduarda Tavares Mariano, Franklim Barbosa da Silva, Eduarda Azevedo Pimentel, Isabela Regina Velten, Luíza Fricks Cabellino, Gabriel Bueno Fonseca, Laysa Moreira Pertele, Maria Nogueira da Costahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMariano, Maria Eduarda TavaresSilva, Franklim Barbosa daPimentel, Eduarda AzevedoVelten, Isabela ReginaCabellino, Luíza FricksFonseca, Gabriel BuenoPertele, Laysa MoreiraCosta, Maria Nogueira da2023-12-27T19:51:49Zoai:ojs.bjihs.emnuvens.com.br:article/1159Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2023-12-27T19:51:49Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
EPIDEMIOLOGICAL PROFILE OF MALIGNANT NEOPLASIA OF THE PANCREAS IN ADULTS IN BRAZIL BETWEEN 2017 TO 2022 PERFIL EPIDEMIOLÓGICO DA NEOPLASIA MALÍGNA DE PÂNCREAS EM ADULTOS NO BRASIL ENTRE 2017 A 2022 |
title |
EPIDEMIOLOGICAL PROFILE OF MALIGNANT NEOPLASIA OF THE PANCREAS IN ADULTS IN BRAZIL BETWEEN 2017 TO 2022 |
spellingShingle |
EPIDEMIOLOGICAL PROFILE OF MALIGNANT NEOPLASIA OF THE PANCREAS IN ADULTS IN BRAZIL BETWEEN 2017 TO 2022 Mariano, Maria Eduarda Tavares Saúde masculina, Neoplasia, Pâncreas, tumores. Men's health, Neoplasia, Pancreas, tumors. |
title_short |
EPIDEMIOLOGICAL PROFILE OF MALIGNANT NEOPLASIA OF THE PANCREAS IN ADULTS IN BRAZIL BETWEEN 2017 TO 2022 |
title_full |
EPIDEMIOLOGICAL PROFILE OF MALIGNANT NEOPLASIA OF THE PANCREAS IN ADULTS IN BRAZIL BETWEEN 2017 TO 2022 |
title_fullStr |
EPIDEMIOLOGICAL PROFILE OF MALIGNANT NEOPLASIA OF THE PANCREAS IN ADULTS IN BRAZIL BETWEEN 2017 TO 2022 |
title_full_unstemmed |
EPIDEMIOLOGICAL PROFILE OF MALIGNANT NEOPLASIA OF THE PANCREAS IN ADULTS IN BRAZIL BETWEEN 2017 TO 2022 |
title_sort |
EPIDEMIOLOGICAL PROFILE OF MALIGNANT NEOPLASIA OF THE PANCREAS IN ADULTS IN BRAZIL BETWEEN 2017 TO 2022 |
author |
Mariano, Maria Eduarda Tavares |
author_facet |
Mariano, Maria Eduarda Tavares Silva, Franklim Barbosa da Pimentel, Eduarda Azevedo Velten, Isabela Regina Cabellino, Luíza Fricks Fonseca, Gabriel Bueno Pertele, Laysa Moreira Costa, Maria Nogueira da |
author_role |
author |
author2 |
Silva, Franklim Barbosa da Pimentel, Eduarda Azevedo Velten, Isabela Regina Cabellino, Luíza Fricks Fonseca, Gabriel Bueno Pertele, Laysa Moreira Costa, Maria Nogueira da |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Mariano, Maria Eduarda Tavares Silva, Franklim Barbosa da Pimentel, Eduarda Azevedo Velten, Isabela Regina Cabellino, Luíza Fricks Fonseca, Gabriel Bueno Pertele, Laysa Moreira Costa, Maria Nogueira da |
dc.subject.por.fl_str_mv |
Saúde masculina, Neoplasia, Pâncreas, tumores. Men's health, Neoplasia, Pancreas, tumors. |
topic |
Saúde masculina, Neoplasia, Pâncreas, tumores. Men's health, Neoplasia, Pancreas, tumors. |
description |
INTRODUCTION: Pancreatic cancer has a very unfavorable prognosis, with less than 10% survival rate within 5 years after diagnosis. Generally asymptomatic at first, it makes early detection difficult and spreads quickly. Risk factors include age, smoking and obesity, with the latter associated with a higher incidence. Surgical resection, a potentially curative method, is rare due to the location and late detection of tumors, which results in a fatal outcome. Primary health care is crucial in prevention, especially to minimize socioeconomic disparities that can affect incidence. OBJECTIVE: To describe the epidemiological profile of Malignant Neoplasia of the Pancreas in adults in Brazil between 2017 to 2022. METHODOLOGY: Cross-sectional descriptive study with a quantitative and qualitative approach, based on the collection of data present in the Hospital Information System, hosted at DATASUS on Malignant Neoplasia of the Pancreas reported in Brazil between the periods of 2017 and 2022. The data totaled 78,796 hospitalizations in this period. The indicators used were: federation units; gender; age group; education; evolution of the case to death, race/ethnicity and region of occurrence. For the literature review, the keywords and the main subject about Malignant Neoplasia of the Pancreas were relevant using the SciELO and PubMed database platforms. Articles published in the last 13 years that emphasized the description of the disease, its risk factors, the most prevalent histological types, as well as symptoms and prognosis were selected. RESULTS: Between 2017 and 2022, Brazil recorded 78,796 hospitalizations for Malignant Neoplasia of the Pancreas. The Southeast region had the highest occurrence, with 47.5% of cases, with SP being the most affected state, followed by MG, RS and PR. CONCLUSION: From 2017 to 2022, pancreatic cancer was more prevalent in Southeast Brazil, mainly in São Paulo, totaling 78,796 cases. Population density, socioeconomic conditions and access to advanced medical centers influenced this distribution. Adenocarcinoma represented 90% of cases. Remarkable advances have been made, including the identification of risk factors such as smoking and obesity, and the association with glucose problems and diabetes as early indicators. CT scanning is vital for diagnosis, but understanding genetic mutations remains a necessary area of investigation. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-12-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1159 10.36557/2674-8169.2023v5n5p6444-6453 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/1159 |
identifier_str_mv |
10.36557/2674-8169.2023v5n5p6444-6453 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1159/1321 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 5 No. 5 (2023): BJIHS QUALIS B3; 6444-6453 Brazilian Journal of Implantology and Health Sciences ; Vol. 5 Núm. 5 (2023): BJIHS QUALIS B3; 6444-6453 Brazilian Journal of Implantology and Health Sciences ; v. 5 n. 5 (2023): BJIHS QUALIS B3; 6444-6453 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1796798442933059584 |